Crossmark Global Holdings Inc. Has $4.76 Million Position in Haleon plc (NYSE:HLN)

Crossmark Global Holdings Inc. boosted its position in Haleon plc (NYSE:HLNFree Report) by 3.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 499,430 shares of the company’s stock after purchasing an additional 18,670 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Haleon were worth $4,764,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Fortitude Family Office LLC bought a new position in shares of Haleon during the third quarter worth approximately $28,000. Versant Capital Management Inc grew its position in Haleon by 2,029.1% during the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock worth $34,000 after buying an additional 3,348 shares in the last quarter. Toronto Dominion Bank increased its stake in Haleon by 3,470.0% during the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after acquiring an additional 3,470 shares during the period. Prospera Private Wealth LLC acquired a new position in Haleon in the 3rd quarter valued at $57,000. Finally, Brooklyn Investment Group lifted its position in shares of Haleon by 168.1% during the 4th quarter. Brooklyn Investment Group now owns 6,080 shares of the company’s stock valued at $58,000 after acquiring an additional 3,812 shares during the period. 6.67% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts recently commented on HLN shares. UBS Group upgraded Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. Morgan Stanley cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Finally, Sanford C. Bernstein lowered shares of Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $10.95.

Read Our Latest Analysis on Haleon

Haleon Stock Performance

NYSE:HLN opened at $9.23 on Thursday. Haleon plc has a twelve month low of $7.89 and a twelve month high of $10.80. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The stock’s 50-day simple moving average is $9.54 and its 200 day simple moving average is $9.72. The firm has a market capitalization of $41.76 billion, a PE ratio of 27.13, a price-to-earnings-growth ratio of 2.59 and a beta of 0.29.

Haleon (NYSE:HLNGet Free Report) last posted its quarterly earnings results on Thursday, October 31st. The company reported $0.14 earnings per share for the quarter, beating analysts’ consensus estimates of $0.11 by $0.03. The company had revenue of $3.62 billion for the quarter, compared to the consensus estimate of $3.74 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. During the same period last year, the company posted $0.10 EPS. On average, analysts anticipate that Haleon plc will post 0.44 EPS for the current fiscal year.

About Haleon

(Free Report)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Featured Articles

Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon plc (NYSE:HLNFree Report).

Institutional Ownership by Quarter for Haleon (NYSE:HLN)

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.